Back to Trades
Carter Todd Alfred
Chief Scientific OfficerCIK 0001944011
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2026
Carter Todd Alfred, Chief Scientific Officer, has filed 2 SEC reports (2026), all concentrated in Voyager Therapeutics, Inc. (VYGR), totaling $582.4K in disclosed volume. Weighing $0 bought versus $15.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 26 | VYGR Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Sell | $15.7K |
| Feb 10 | VYGR Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Grant | $566.7K |
2 filings